Deutsche Bank Adjusts Omega Healthcare Investors Price Target to $38 From $36, Maintains Buy Rating
RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating
Omega Healthcare Invts Analyst Ratings
J.P. Morgan Securities: Reiterates Omega Healthcare Invts (OHI.US) Market's unanimous rating.
Omega Healthcare Invts Analyst Ratings
Omega Healthcare Invts Analyst Ratings
Citigroup Upgrades Omega Healthcare Invts to Buy, Raises Price Target to $35
Omega Healthcare Invts Analyst Ratings
Wells Fargo Keeps Their Hold Rating on Omega Healthcare (OHI)
Exane BNP Paribas Upgrades Omega Healthcare Invts to Neutral, Announces $30 Price Target
Omega Healthcare Invts Analyst Ratings
RBC Capital Sticks to Its Hold Rating for Omega Healthcare (OHI)
Deutsche Bank Initiates Coverage On Omega Healthcare Invts With Buy Rating, Announces Price Target of $36
Omega Healthcare Invts Analyst Ratings
Omega Healthcare Invts Analyst Ratings
Mizuho Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $34
Omega Healthcare Invts Analyst Ratings
Truist Securities Maintains Hold on Omega Healthcare Invts, Lowers Price Target to $31
Omega Healthcare Invts Analyst Ratings
Wells Fargo Maintains Equal-Weight on Omega Healthcare Invts, Lowers Price Target to $33
No Data